Connection
Ping-Ching Hsu to High-Throughput Nucleotide Sequencing
This is a "connection" page, showing publications Ping-Ching Hsu has written about High-Throughput Nucleotide Sequencing.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.200 |
|
|
|
-
Hsu PC, Chang JW, Chiu LC, Yang CT, Kuo SC, Fang YF, Wu CE. Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy. Clin Transl Oncol. 2025 May; 27(5):1967-1979.
Score: 0.200